ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 289 out of 2429

$615K Total Retail Price of All Prescriptions

Rank: 174 out of 2429

323 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 323 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
METFORMIN HCL 372 330 1 8
CRESTOR 324 302 2 25
AMLODIPINE BESYLATE 320 302 3 4
SIMVASTATIN 281 263 4 1
FUROSEMIDE 280 255 5 5
ATORVASTATIN CALCIUM 259 226 6 13
LISINOPRIL 255 220 7 2
LEVOTHYROXINE SODIUM 243 202 8 3
CARVEDILOL 214 196 9 21
METOPROLOL TARTRATE 212 200 10 9
HYDROCHLOROTHIAZIDE 170 155 11 10
CLOPIDOGREL 168 154 12 31
METOPROLOL SUCCINATE 167 144 13 12
HYDROCODONE-ACETAMINOPHEN 160 120 S3 14 6
RAMIPRIL 147 128 15 118
PLAVIX 132 126 16 44
POTASSIUM CHLORIDE 131 113 17 14
WARFARIN SODIUM 131 122 17 11
PANTOPRAZOLE SODIUM 127 127 19 34
ZETIA 118 104 20 70
GABAPENTIN 111 91 21 18
ALENDRONATE SODIUM 104 104 22 20
OMEPRAZOLE 98 82 23 7
SPIRONOLACTONE 89 83 24 62
SYNTHROID 87 85 25 93
ALLOPURINOL 85 64 26 33
ISOSORBIDE MONONITRATE ER 84 59 27 55
DIGOXIN 80 69 28 43
KLOR-CON 10 80 75 28 89
VESICARE 79 79 30 158
NEXIUM 77 58 31 37
FENOFIBRATE 73 49 32 48
TRAMADOL HCL 72 65 33 17
CITALOPRAM HBR 72 59 33 19
ZOLPIDEM TARTRATE 68 27 35 28
DIOVAN HCT 68 68 35 83
TAMSULOSIN HCL 63 63 37 29
LOSARTAN-HYDROCHLOROTHIAZIDE 62 46 38 73
DONEPEZIL HCL 59 59 39 26
FLUOXETINE HCL 54 46 40 61
CIPROFLOXACIN HCL 54 49 40 84
SERTRALINE HCL 53 43 42 23
LOSARTAN POTASSIUM 52 43 43 22
ATENOLOL 52 46 43 15
NIASPAN 52 36 43 113
PRAVASTATIN SODIUM 50 50 46 16
TRICOR 50 49 46 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.